Objective: To evaluate the potential role of low serum Ca levels in the occurrence of sudden cardiac arrest (SCA) In multivariable logistic regression analysis, a 1-unit decrease in Ca levels was associated with a 1.6-fold increase in odds of SCA (odds ratio, 1.63; 95% CI, 1.06-2.51). Blood Ca levels lower than 8.95 mg/dL (to convert to mmol/L, multiply by 0.025) were associated with a 2.3-fold increase in odds of SCA as compared with levels higher than 9.55 mg/dL (odds ratio, 2.33; 95% CI, 1.17-4.61). Cases of SCA had significantly prolonged corrected QT intervals on the 12-lead electrocardiogram than did controls (465AE37 ms vs 425AE33 ms; P<.001). Conclusion: Lower serum Ca levels were independently associated with an increased risk of SCA in the community.
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However, more than half of men and close to 70% of women who die of SCA have no clinical history of heart disease before their cardiac arrest. 2, 3 Hence, it is important to identify other risk factors and mediators for SCA to improve risk stratification and preventive strategies in the general population.
Electrolyte abnormalities are known to induce or facilitate clinical arrhythmia even in normal cardiac tissue, and they can lead to SCA. 4 Calcium is an essential cation for the myocardial action potential and excitation-contraction coupling of cardiac muscle. 5 Importantly, low serum Ca levels are associated with an increased risk of SCA in patients on dialysis. 6 However, the evidence for the relationship between Ca intake and cardiovascular events is mixed and at times contradictory. In some observational studies, a strong inverse or neutral relationship was noted between Ca intake and mortality from ischemic heart disease. 7, 8 In addition, communities with a Ca-rich water supply seem to have a lower incidence of cardiovascular events. 9 In contrast, there are reports of an upward trend in cardiovascular event rates including myocardial infarction and sudden death in postmenopausal women who received Ca supplementation, resulting in higher blood Ca levels. 10, 11 In summary, it is not clear whether blood Ca levels are related to SCA in the general population. Therefore, we evaluated the association between serum Ca levels and SCA in a large communitybased study, also adjusting for renal function. PATIENTS AND METHODS Case and control subjects were ascertained in the Oregon Sudden Unexpected Death Study, a prospective ongoing population-based study of SCA started on February 1, 2002 , in the Portland, Oregon, metropolitan region (catchment population w1 million individuals). The details of the design and ascertainment of cases and controls have been reported previously. 12, 13 In brief, cases of out-of-hospital cardiac arrest are identified from multiple sources including county medical examiner's office, emergency medical response system (ambulance and fire services), and local hospital emergency departments. Cases also included survivors of SCA. Since 2002, the Oregon Sudden Unexpected Death Study has reviewed all SCAs with emergency medical response system response as well as additional cases from the medical examiner and hospitals. Sudden cardiac arrest was defined as a sudden unexpected pulseless condition if witnessed or unexpected death within 24 hours of last having been observed in the usual state of health if unwitnessed. Sudden cardiac arrest was adjudicated by 3 in-house physicians after reviewing all available medical records or autopsy reports for each subject, 12 and all SCAs meeting inclusion criteria were enrolled. Noncardiac etiologies such as trauma, chronic terminal illness, and drug overdose were excluded. Control subjects were enrolled during the same time period and from the same geographical region as the cases from multiple sources within the Portland metropolitan region, including emergency medical services that treated patients with chest pain, outpatient local hospital clinics, patients undergoing coronary angiogram at a participating hospital system, and a local large health maintenance organization (HMO). From the first 3 sources, all potential control subjects were identified, contacted, consented, and enrolled if they had documented coronary artery disease (CAD), defined by history of myocardial infarction, revascularization, or angiogram with 50% or more stenosis in a major coronary artery. Controls were excluded if they had a history of ventricular arrhythmia or SCA. 12 For HMO controls, a random sample of HMO members (half with documented CAD, half without) were frequency matched to cases by age and sex and were enrolled using the same procedures described above. The control population was selected to represent the source population of the cases, with a predominance of individuals with documented CAD to adequately control for CAD in casecontrol comparisons. Eighty percent of control subjects had a diagnosis of CAD to match the estimate of CAD among the cases reported in previous community-based studies. 14 For both cases and controls, electrolyte levels were obtained from the results of clinical laboratory tests performed during routine clinical practice, if available in patients' medical records. Cases for this analysis were included if they were enrolled from February 1, 2002, through December 31, 2015, and their electrolyte levels were measured within the 90 days of SCA. Subjects were excluded if their age was less than 18 years or if there were no available creatinine clearance (CrCl), serum Ca, or serum albumin level measurements. The CrCl level was calculated using the Cockcroft-Gault formula. 15 Although free (ionized) Ca is more physiologically relevant than total Ca, measured ionized Ca was not available from most routine clinical laboratory test results. Therefore, serum Ca levels were corrected using the concomitantly measured serum albumin levels and using a widely used formula {corrected Ca level in mg/dL¼uncorrected value in mg/dLþ[0.8(4Àalbumin level in g/ dL)]}. 16, 17 Normal albumin levels were set at 4 g/dL (to convert to g/L, multiply by 10). Detailed clinical information was obtained for all subjects from review of all available medical records. The QT interval was measured from archived standard resting 12-lead electrocardiograms with a paper speed of 25 mm/s and a calibration of 10 mm/mV (before and unrelated to the cardiac arrest in cases) and corrected for heart rate using Bazett's formula. Only electrocardiograms performed within 90 days before the arrest were included.
For this analysis, laboratory test results obtained within 90 days of the arrest were chosen for SCA cases because results would indicate the patient's electrolyte status shortly before the arrest. Overall, cases with laboratory test results available within 90 days of arrest were somewhat older and had a higher comorbidity burden (mean age, 66.1 years; 67% men; 77% hypertension; 45% diabetes; 38% chronic kidney disease) than did cases with laboratory test results available more than 90 days before the arrest (mean age, 65.0 years; 68% men; 69% hypertension; 37% diabetes; 23% chronic kidney disease).
Statistical Analyses
Continuous variables are presented as mean AE SD, and categorical variables are reported as frequencies and percentages (Table 1) . Categorical and continuous variables including demographic characteristics and laboratory results were compared between cases and controls using chi-square and Student t tests. Examination of continuous variables indicated that all were relatively normally distributed, with median values close to mean values. Nonparametric Wilcoxon rank-sum tests for case-control comparisons for Ca, K, CrCl, and albumin produced similar results, and thus we have used t tests for all continuous variables. As expected in a case-control study, cases had a higher burden of risk factors for SCD than for control subjects whose risk factor burden should be representative of the larger source population from which cases arose. To adjust for these differences, multivariable logistic regression was used to estimate the independent association of Ca levels with SCA. The association was adjusted for confounders in 3 models ( Table 2 ). The confounders were chosen from the covariates listed in Table 1 because of their potential association with both Ca levels and SCA. A 2-tailed P value of .05 or less was considered statistically significant. Statistical analyses were performed using Stata version 11 (StataCorp LP). Quartiles of plasma-corrected Ca levels were created on the basis of the distribution of plasma-corrected Ca levels among the controls, and cases were assigned to the appropriate category. The median levels of plasma Ca in each quartile were used as a continuous variable for estimating the linear trend across all quartiles.
RESULTS
A total of 712 subjects were included in this study: 267 cases (66% men) and 445 controls (71% men) ( Table 1) . Cases had a significantly higher percentage of African Americans, diabetes mellitus, chronic obstructive pulmonary disease, and chronic kidney disease than did controls (P<.001 for all). Cases were also more likely than controls to be on hemodialysis (12% vs 1%; P<.001). In addition, diuretics, especially loop diuretics, were prescribed more for cases than for controls (P<.001) with no differences in the rate of utilization of b-blockers (P¼.11). Among the laboratory values, cases had lower corrected Ca levels than did controls (9.18AE0.56 vs 9.27AE0.56; P¼.03). Calcium values ranged from 7.28 to 11.3 mg/dL in cases and from SERUM CALCIUM AND SUDDEN CARDIAC ARREST 7.7 to 12.5 mg/dL in controls. In individuals not undergoing hemodialysis, the results were nearly identical, with Ca levels for cases being 9.16AE0.54 mg/dL and for controls 9.27 AE 0.56 mg/dL (P¼.02). In addition, cases had lower CrCl levels (P<.001), higher serum potassium levels (P<.001), and lower albumin levels (P<.001). Evaluation of electrocardiograms revealed significantly longer QRS and heart rateeadjusted QT intervals in cases than in controls (P¼.01 and P<.001, respectively). Echocardiograms were performed in 171 cases (64%) and 255 controls (57%), and the mean left ventricular ejection fraction (LVEF) was significantly lower in cases (48% vs 54%; P<.001). However, only 40 cases (23% of all who had echocardiogram results) and 26 controls (10%) had LVEF less than 35%.
In the age, sex, race, and body mass index (calculated as the weight in kilograms divided by the height in meters squared)eadjusted model (model 1), Ca levels were inversely associated with SCA (P<.001 for trend) and patients in the lowest quartile of blood Ca level (Ca level<8.95 mg/dL) as compared with those in the highest quartile (Ca level>9.55 mg/dL) had a significantly higher risk of SCA (odds ratio [OR], 1.91; 95% CI, 1.22-2.99) ( Table 2) . Further adjustment for history of hypertension, diabetes, chronic obstructive pulmonary disease, hypothyroidism, and CrCl level revealed higher OR for SCA (model 2) when comparing the lowest quartile with the highest. Finally, upon adding LVEF, potassium level, and use of diuretics (loop and nonloop) and b-blockers to the model, the lowest quartile (Ca level<8.95 mg/dL) exhibited a significant increase in odds of SCA (2.3-fold) as compared with the highest quartile (model 3; P<.001).
As a sensitivity analysis, we repeated the analysis excluding subjects on hemodialysis. The results were similar to the overall results, with ORs of approximately 2.0 comparing the lowest vs highest quartile of Ca level, with a significant linear trend (P<.02) in all 3 multivariable models.
In multivariable logistic regression analysis, a 1-unit decrease in Ca levels was associated with a 1.6-fold increase in odds of SCA (OR, 1.63; 95% CI, 1.06-2.51) when Ca level was treated as a continuous variable (after adjustment for all the variables included in model 3). Compared with the cases constituting the highest quartile of blood Ca level (cases with Ca level >9.55 mg/dL), those in the lowest quartile had a lower rate of b-blocker use and a trend toward a higher CrCl level (P¼.04 and P¼.05, respectively) (Table 3 ). However, there was no significant difference between these quartiles in their demographic characteristics, comorbidities, LVEF, and potassium levels (P>.05). The heart rateeadjusted QT interval was somewhat longer in the lowest quartile, but this difference was not statistically significant (P¼.52).
DISCUSSION
In this large prospective population-based study, lower Ca levels measured within 90 days before SCA were associated with a higher risk of SCA. These findings indicate that patients with Ca levels lower than 8.95 mg/dL have a 2.3-fold higher risk of SCA than do those with Ca levels higher than 9.55 mg/dL. This inverse relationship between Ca levels and SCA is consistent with the hypothesis that lower Ca levels may independently modify the risk of SCA.
To the best of our knowledge, there is no information available on the correlation between blood Ca level and SCA in the general population. Calcium intake or level has mainly been studied in relation to bone health and in regard to its supplementation and cardiovascular safety. 18 Nevertheless, multiple cohort studies with long duration of follow-up using baseline Ca levels have investigated the association of serum Ca levels and cardiovascular or all-cause mortality in different populations and subgroups. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] These reports found conflicting results, with both high and low levels of Ca reported to be associated with an increase in cardiovascular events. Leifsson and Ahren 19 found that the risk of premature death, which was largely attributed to cardiovascular disease, increases in men younger than 50 years with increasing Ca levels even in the normal range. They followed these patients for 11 years. In another study reported by Grandi et al, 20 a cohort of patients with stable CAD were followed for 8 years and they reported significantly higher all-cause mortality in patients with higher adjusted baseline Ca levels. Grandi et al suggested that the higher Ca level might contribute to progressive vascular calcification and its related morbidities resulting in higher cardiovascular adverse events. Furthermore, Lundgren et al 21 reported that mild hypercalcemia is associated with premature cardiovascular death. These patients were followed for approximately 2 decades. In contrast to the above-mentioned studies, Ogard et al 22 were unable to find any correlation between upper quartiles of serum ionized Ca levels and higher incidence of cardiovascular diseases in 45-year-old men and women followed for 18 years. Similar to Ogard et al, Palmer et al 23 conducted a meta-analysis study to assess the association between all-cause mortality and serum Ca levels in patients with chronic kidney disease and reported no significant association.
However, Palmer et al do list some concerns about the studies included in their metaanalysis, stating that few of the studies had met their criteria for completeness.
More recently, a study reported that lower Ca levels increase the risk of cardiovascular death in men and decrease the risk in women. 24 However, the test for interaction by sex was not statistically significant and therefore the authors stated that this reverse association might be due to chance. In addition, Zittermann et al reported that Ca levels were significantly higher in event-free survivors than in nonsurvivors of end-stage heart failure in short-term follow-up. 26 Similarly, Miura et al 27 reviewed patients with heart failure and chronic kidney disease and reported that cardiac and all-cause mortality was significantly higher in the low Ca group than in the normal to high Ca group. Finally, in patients with ST-elevation myocardial infarction, lower Ca levels at the time of admission were associated with higher inhospital mortality. 28 Published cohort studies generally have a long duration of follow-up after the baseline measurements of Ca levels and therefore may not reflect the patients' Ca status in the months and days before the event. In the present study, the level of Ca was evaluated within 90 days before the event.
There are some potential explanations for the association of lower Ca levels, even within the normal range of values, with increased risk of SCA. First, low serum Ca levels can prolong the action potential duration. 4, 5 If serum Ca levels are low enough or when other factors that can prolong QT interval exist, lifethreatening arrhythmias such as torsades de pointes can occur. 29, 30 The present study supports this possibility as the corrected QT intervals were longer in our cases than in controls. Second, low Ca levels have been associated with heart failure and diastolic dysfunction. 31 Gromadzinski et al 31 reported that the low serum Ca level is the only independent predictive factor for left ventricular diastolic dysfunction (independent of parathyroid hormone) in patients with chronic kidney disease. Third, the effect of low extracellular Ca on cell death and stroke was studied in preclinical models and the low levels paradoxically increased the overloading of intracellular Ca, which could potentiate apoptosis during ischemic episodes. 32 The same phenomenon may exist in cardiac tissues in the setting of ischemia. Fourth, lower Ca levels may increase parathyroid hormone levels, also linked with various deleterious cardiovascular effects. [33] [34] [35] This analysis is based on a single measurement of plasma Ca. Although the study found a statistically significant inverse relationship between Ca level and SCA, serial measurements may provide a better assessment of this correlation. Similar to other observational studies, residual confounding could contribute to the relationship observed. Another limitation of this study is lack of complete data on drug therapies, their dosage, and level of adherence. To assess whether bias was introduced by choosing the patients with available serum Ca levels, we compared 2 groups (subjects with available Ca levels vs no levels available) by age, body mass index, and CrCl level and no significant differences were found (P¼.8). Nevertheless, this analysis does not eliminate the possibility of bias on the basis of other uncontrolled factors. Overall, it seems that further study is required to elucidate the mechanisms underlying the adverse associations with lower Ca levels and to determine whether controlling Ca levels improves the prognosis in the general population or in high-risk patients.
CONCLUSION
Lower serum Ca levels were independently associated with an increased risk of SCA in the general population. These findings have potential implications for mechanisms as well as prevention of SCA and warrant further evaluation.
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